Batefenterol CAS 743461-65-6

Pwodwi Deskripsyon:

Non pwodwi: Batefenterol CAS NON: 743461-65-6

 

Sinonim:

biphenyl-2-ylcarbamicacid1-[2-(2-chloro-{[(R) -2-hydroxy-2-(8-hydroxy-2-oxo- 1,2-dihydroquinolin-5-yl) ethylamino]methyl}-5-methoxyphylcarmoyl) ethyl]-piperidin-4-yl ester;

1-(3-(2-chloro-4-(((2R) -2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl) ethyl)amino)-5-methoxyphenyl)-3-oxopropyl)piperidin-4-yl [1,1'biphenyl]-2-ylcarbamate;

 

Chimik & Pwopriyete fizik:

Aparans: Crystalline solid

Assay: ≥98.0%

Dansite: 1.41±0.1 g / cm3 (Predicted)

Bouyi pwen: 948.3±65.0 ° C (predi)

Pka: 8.89±0.20 (Prediksyon)

Flash Point: 527.3±34.3° C

Vapore Presyon: 0.0±0.3 mmHg nan 25 ° C

Endeks refraksyon: 1.692

 

Batefenterol (GSK961081; TD-5959) se yon resepte mizik rsepteur mizik ak β2-adrenocepteur agonis; montre afinesite segonde pou hM2, hM3 misikrinik ak hβ2-adrenocepteur ak Ki vale de 1.4, 1.3 ak 3.7 nM, respektivman.

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

Baj popilè: batefenterol cas 743461-65-6, manifaktire, founise, faktori, achte, nan stock

• On: BAR 501 CAS 1632118-69-4
• Pwochen: GSK-461364 CAS 929095-18-1